Discovery of WD-890: A novel allosteric TYK2 inhibitor for the treatment of multiple autoimmune diseases
Article in Biomedicine & Pharmacotherapy (September 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis
Article in In Vivo (August 2023)
Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis
Article in Scientific Reports (March 2018)